PCG
EW icon

Prosperity Consulting Group’s Edwards Lifesciences EW Stock Holding History

Prosperity Consulting Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$495K Buy
5,470
+1,646
+43% +$138K 0.02% 392
2026
Q1 		$306K Buy
3,824
+87
+2% +$7.17K 0.01% 418
2025
Q4 		$319K Buy
3,737
+96
+3% +$7.88K 0.01% 419
2025
Q3 		$283K Sell
3,641
-663
-15% -$51.8K 0.01% 425
2025
Q2 		$337K Buy
4,304
+132
+3% +$9.85K 0.02% 358
2025
Q1 		$302K Buy
4,172
+266
+7% +$19K 0.02% 367
2024
Q4 		$289K Buy
3,906
+134
+4% +$9.38K 0.02% 387
2024
Q3 		$249K Buy
+3,772
New +$274K 0.02% 406

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Prosperity Consulting Group's EW Position: Q2 2026 in Review

Prosperity Consulting Group increased its Edwards Lifesciences (EW) stake by 43% in Q2 2026, buying an estimated $138K and bringing the position to 5,470 shares worth $495K. The position accounts for 0.02% of the portfolio, ranked #392.

Prosperity Consulting Group first reported a position in EW in Q3 2024 and has held it in 8 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Prosperity Consulting Group held 5,470 shares of Edwards Lifesciences worth $495K as of Q2 2026.
  • Prosperity Consulting Group bought 1,646 Edwards Lifesciences shares in Q2 2026, an estimated $138K.
  • Edwards Lifesciences made up 0.02% of Prosperity Consulting Group's portfolio in Q2 2026, its #392 holding.
  • Prosperity Consulting Group first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 8 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Prosperity Consulting Group's 13F filing for Q2 2026, filed 13 Aug 2026.